Get the app
US › Healthcare

Strata Critical Medical, Inc. (SRTA)

US · Healthcare · Medical Care Facilities

$4.54+4.61%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$72.5M
Revenue YoY
+2.4%
Net profit
$-10.5M
EPS
$-0.01
EPS estimate
$-0.01
Net margin
-14.5%

EPS came in at -0.01 against a street estimate of -0.01 — a beat of 0.0%.

Key statistics

Market cap
$393.7M
Forward P/E
138.9
P/B
1.71
Book value
$3.16
EPS (TTM)
$-0.28
52-week high
$6.50
52-week low
$3.95
50-day MA
$5.45
200-day MA
$5.15
Beta
2.43

Analyst view

Analysts rate Strata Critical Medical, Inc. a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $9.56.

Shareholding

Insiders
14.32%
Institutions
71.66%

Largest institutional holders

FundStake
Third Point, LLC5.65%
Becker Drapkin Management, L.P.5.53%
BlackRock Inc5.47%
Arnhold & S. Bleichroeder Advisers, LLC5.23%
Royce & Associates, LP3.54%
Vanguard Capital Management, LLC3.26%
Awm Investment Company Inc3.19%
ARK Investment Management LLC3.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Strata Critical Medical, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.